MOCK FDA INSPECTION SERVICES
BioBoston CRO provides mock FDA inspection and clinical inspection readiness services for sponsors, sites, laboratories, and vendors that need to test people, records, systems, and response processes before an announced or reasonably anticipated inspection. Support can include readiness assessment, interview preparation, document-room simulation, mock investigator interviews, response coaching, observation reporting, and remediation planning.
Global Reach
Therapeutic Area Coverage
Years of Experience
START A CONVERSATION
Select the support you need and share a few details about your project. We’ll use this information to route your inquiry to the appropriate BioBoston team member.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
The engagement should be scoped around the current state of the work, the intended decision or milestone, the source package, and the sponsor's approval responsibilities.
Prioritize high-risk systems, studies, records, roles, logistics, interview readiness, and document retrieval against the available time.
Test sponsor oversight, trial conduct, safety, monitoring, data, vendor controls, electronic systems, TMF evidence, and response governance.
Evaluate facilities, processes, records, personnel responses, evidence availability, and issue escalation under realistic inspection conditions.
when needed
Problems
The service is most valuable when the team can identify the specific control gap, decision, deliverable, or
recovery need rather than requesting generic capacity.
Scope
The exact scope depends on the maturity of the work, the quality of the inputs, the sponsor’s procedures,
the review model, and the target milestone.
Deliverables
Deliverables should be confirmed at kickoff and linked to defined sponsor decisions, review cycles, and downstream handoffs.
Client inputs
The sponsor does not need every detail finalized before kickoff, but approved decisions, open questions, source owners, reviewers, and deadlines must be distinguishable.
Process
1. Confirm the purpose, current state, intended use, milestone, stakeholders, responsibilities, systems or vendors, and agreed deliverables.
2. Review available source materials, prior decisions, procedures, evidence, and open issues; issue a focused gap and dependency list.
3. Develop the work plan, specifications, document, assessment, or control package included in scope.
4. Coordinate review through named sponsor and cross-functional decision owners and maintain a controlled open-item and comment process.
5. Perform the agreed technical, quality, consistency, or operational checks and document remaining risks or limitations.
6. Prepare the approved handoff, implementation, submission, remediation, archive, or next-step package as defined in scope.
Considerations
The work should remain proportionate to the risk and intended use, follow the sponsor’s controlled process, and preserve clear sponsor decision authority.
Engagement options
BioBoston leads the defined scope from assessment and planning through drafting or execution, review, quality control, and handoff.
BioBoston addresses a specific section, decision, backlog, finding, vendor issue, or stalled deliverable without expanding the engagement unnecessarily.
BioBoston provides an objective second-line review, oversight role, or embedded specialist while the sponsor or another vendor retains primary execution.
RELATED SERVICES
Conduct independent audits of studies, sites, vendors, systems, or processes against applicable Good Clinical Practice requirements.
Assess Trial Master File completeness, quality, contemporaneous filing, traceability, and inspection readiness.
Investigate, remediate, and verify issues identified during readiness work, audits, inspections, or quality events.
Strengthen the evidence showing how delegated clinical activities are directed, reviewed, verified, and escalated.
Expertise
Mock-inspection leadership should match the likely inspection program, organization type, product, study phase, systems, functional risks, and inspection history.
RESOURCES
Explore the following resources for additional insights and information relevant to this service.
A planned checklist for scope, people, facilities, records, systems, logistics, interviews, requests, responses, escalation, and remediation.
A planned guide to role preparation, truthful response principles, evidence use, follow-up handling, and escalation.
A planned tool for requests, clarification, ownership, review, approval, delivery, follow-up, and closure.
Meta description Use this FDA inspection request log and mock inspection agenda template to control requests, ownership, review, delivery, follow-up, and closure.
FAQs
Scope may include readiness assessment, agenda and sampling design, opening and closing meetings, document requests, interviews, process walk-throughs, request-room simulation, coaching, observations, reporting, and remediation planning.
Duration depends on the inspection type, sites, studies, systems, risk, prior findings, participants, and available time. The package should be scoped to test material risks rather than meet an arbitrary number of days.
Yes, when scope and access allow. The work should prioritize critical people, records, systems, unresolved findings, inspection logistics, and response controls rather than attempt an unrealistic full
review.
No. An audit independently assesses conformance and evidence against defined criteria. A mock inspection simulates regulator behavior, requests, interviews, logistics, and response management to test readiness.
Yes. Remediation may include root-cause support, CAPA planning, document and process changes, evidence review, training interfaces, implementation checks, and retesting.
No. A mock inspection can identify and reduce readiness risk, but it cannot reproduce every regulatory question or guarantee inspection outcomes.
PROJECT FORM
Share the inspection context, announced date if applicable, organization, studies or products, systems, sites, prior findings, readiness work completed, and highest-risk areas. A BioBoston team member will review the request and follow up regarding fit and possible next steps.
Please do not submit confidential, patient-identifiable, or proprietary information through this form.
A productive first discussion identifies the expected inspection, scope, participants, systems, evidence, prior findings, time available, and readiness concerns. BioBoston can then define a focused simulation, coaching, reporting, and remediation plan.
